Pay in 4 interest-free payments of $7.15 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
[PMC free article: PMC2488223] [PubMed: 18467448] 11
The Achilles Tendon Transection Model Foundational Evidence The Sikiric laboratorys Achilles tendon transection research established the foundational tissue-repair evidence base for BPC-157
BPC-157/TB-500 10+10mg $160.00 Volume discounts Auto-applied at checkout Free shipping on orders of $200+ Compound Identity COMPOUND NAME BPC-157 and TB-500 peptide blend SYNONYMS Body Protection Compound-157 (BPC-157), Thymosin Beta-4 Fragment (TB-500) CAS NUMBER BPC-157: 137525-51-0 TB-500: 77591-33-4 MOLECULAR FORMULA BPC-157: C 62 H 98 N 16 O 22 TB-500: C 212 H 350 N 56 O 78 S MOLECULAR WEIGHT BPC-157: 1419.53552 g/mol TB-500: ~4963.49 g/mol STRUCTURE Synthetic tetrapeptide PEPTIDE SEQUENCE BPC-157: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val TB-500: Ac-Ser-Asp-Lys-Pro-Asp-Met-Ala-Glu-Ile-Glu-Lys-Phe-Lys-Asp-Lys-Ser-Ile-Lys-Asn-Asp-Lys-Pro-Thr CHEMICAL STRUCTURE BPC-157: TB-500: CHEMICAL STRUCTURE BPC-157: C 62 H 98 N 16 O 22 TB-500: C 212 H 350 N 56 O 78 S Mechanism of Action BPC-157 is believed to act via modulation of nitric oxide pathways, angiogenesis induction, and cytoprotective effects through VEGFR-2 and FAK-paxillin pathways
Research Applications (Wolverine Blend Benefits) While BPC-157 and TB-500 are still under investigation and not approved for therapeutic use, preclinical studies have explored their potential in a range of biological contexts
US$ 26.34
US$ 27.87
US$ 28.11
.jpg)
US$ 22.19
US$ 28.05
US$ 25.40
US$ 28.68
US$ 21.79
